Neurobiology of Treatment Responses in MDD

Summary

The primary study intent is to examine biological mechanisms associated with acute and chronic treatment responses in major depressive disorder (MDD). It is hypothesized that treatment responsiveness, representing endogenous opioid system function, will be associated with acute improvements in mood state over a 10-week treatment trial in MDD. Potential (bio) markers of treatment effects will be tested against psychophysical responses to placebo and active treatments.

Timeline

Start

2021-11

Primary completion

2023-05

Completion

2023-05

Outcome

Outcome not reported

Stopped: “Institution was unable to manufacture radiotracer that was central to the protocol. Study transferred to another institution.”

Drugs

Indications